APO RESEARCH · REPORT
Pulmonary Function Testing Systems
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
Product & engineering
Understand the product.
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Selected research
Industry Growth & Trends
Global Pulmonary Function Testing Systems Industry Growth and Trends Forecast to 2032
Market perspective
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.
The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.
Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.
Read the full market overview
Report Scope
This report provides a structured, data-driven view of the global Pulmonary Function Testing Systems market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pulmonary Function Testing Systems market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pulmonary Function Testing Systems market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pulmonary Function Testing Systems.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pulmonary Function Testing Systems market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pulmonary Function Testing Systems Market by Company
CareFusion(BD)
Schiller
CHEST
COSMED
nSpire Health
NDD
MGC Diagnostics
Minato
Ganshorn
AESRI
Morgan Scientific
M&B
Sikeda
RSDQ
Pulmonary Function Testing Systems Segment by Type
Portable PFT Systems
Complete PFT Systems
Pulmonary Function Testing Systems Segment by Application
Hospitals
Physical Examination Center
Physician Groups
Others
Pulmonary Function Testing Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Function Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Function Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Function Testing Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pulmonary Function Testing Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pulmonary Function Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Portable PFT Systems
- Complete PFT Systems
Applications
- Hospitals
- Physical Examination Center
- Physician Groups
- Others
Companies covered
- CareFusion(BD)
- Schiller
- CHEST
- COSMED
- nSpire Health
- NDD
- MGC Diagnostics
- Minato
- Ganshorn
- AESRI
- Morgan Scientific
- M&B
- Sikeda
- RSDQ
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pulmonary Function Testing Systems Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pulmonary Function Testing Systems Sales Estimates and Forecasts (2021-2032)
- 1.3 Pulmonary Function Testing Systems Market by Type
- 1.3.1 Portable PFT Systems
- 1.3.2 Complete PFT Systems
- 1.4 Global Pulmonary Function Testing Systems Market Size by Type
- 1.4.1 Global Pulmonary Function Testing Systems Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pulmonary Function Testing Systems Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pulmonary Function Testing Systems Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pulmonary Function Testing Systems Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pulmonary Function Testing Systems Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pulmonary Function Testing Systems Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pulmonary Function Testing Systems Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pulmonary Function Testing Systems Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pulmonary Function Testing Systems Industry Trends
- 2.2 Pulmonary Function Testing Systems Industry Drivers
- 2.3 Pulmonary Function Testing Systems Industry Opportunities and Challenges
- 2.4 Pulmonary Function Testing Systems Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pulmonary Function Testing Systems Revenue (2021-2026)
- 3.2 Global Top Players by Pulmonary Function Testing Systems Sales (2021-2026)
- 3.3 Global Top Players by Pulmonary Function Testing Systems Price (2021-2026)
- 3.4 Global Pulmonary Function Testing Systems Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pulmonary Function Testing Systems Major Company Production Sites & Headquarters
- 3.6 Global Pulmonary Function Testing Systems Company, Product Type & Application
- 3.7 Global Pulmonary Function Testing Systems Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pulmonary Function Testing Systems Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pulmonary Function Testing Systems Players Market Share by Revenue in 2025
- 3.8.3 2025 Pulmonary Function Testing Systems Tier 1, Tier 2, and Tier 3
4 Pulmonary Function Testing Systems Regional Status and Outlook
- 4.1 Global Pulmonary Function Testing Systems Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pulmonary Function Testing Systems Historic Market Size by Region
- 4.2.1 Global Pulmonary Function Testing Systems Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pulmonary Function Testing Systems Sales in Value by Region (2021-2026)
- 4.2.3 Global Pulmonary Function Testing Systems Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pulmonary Function Testing Systems Forecasted Market Size by Region
- 4.3.1 Global Pulmonary Function Testing Systems Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pulmonary Function Testing Systems Sales in Value by Region (2027-2032)
- 4.3.3 Global Pulmonary Function Testing Systems Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pulmonary Function Testing Systems by Application
- 5.1 Pulmonary Function Testing Systems Market by Application
- 5.1.1 Hospitals
- 5.1.2 Physical Examination Center
- 5.1.3 Physician Groups
- 5.1.4 Others
- 5.2 Global Pulmonary Function Testing Systems Market Size by Application
- 5.2.1 Global Pulmonary Function Testing Systems Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pulmonary Function Testing Systems Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pulmonary Function Testing Systems Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pulmonary Function Testing Systems Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pulmonary Function Testing Systems Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pulmonary Function Testing Systems Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pulmonary Function Testing Systems Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pulmonary Function Testing Systems Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 CareFusion(BD)
- 6.1.1 CareFusion(BD) Company Information
- 6.1.2 CareFusion(BD) Business Overview
- 6.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio
- 6.1.5 CareFusion(BD) Recent Developments
- 6.2 Schiller
- 6.2.1 Schiller Company Information
- 6.2.2 Schiller Business Overview
- 6.2.3 Schiller Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Schiller Pulmonary Function Testing Systems Product Portfolio
- 6.2.5 Schiller Recent Developments
- 6.3 CHEST
- 6.3.1 CHEST Company Information
- 6.3.2 CHEST Business Overview
- 6.3.3 CHEST Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 CHEST Pulmonary Function Testing Systems Product Portfolio
- 6.3.5 CHEST Recent Developments
- 6.4 COSMED
- 6.4.1 COSMED Company Information
- 6.4.2 COSMED Business Overview
- 6.4.3 COSMED Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 COSMED Pulmonary Function Testing Systems Product Portfolio
- 6.4.5 COSMED Recent Developments
- 6.5 nSpire Health
- 6.5.1 nSpire Health Company Information
- 6.5.2 nSpire Health Business Overview
- 6.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 nSpire Health Pulmonary Function Testing Systems Product Portfolio
- 6.5.5 nSpire Health Recent Developments
- 6.6 NDD
- 6.6.1 NDD Company Information
- 6.6.2 NDD Business Overview
- 6.6.3 NDD Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 NDD Pulmonary Function Testing Systems Product Portfolio
- 6.6.5 NDD Recent Developments
- 6.7 MGC Diagnostics
- 6.7.1 MGC Diagnostics Company Information
- 6.7.2 MGC Diagnostics Business Overview
- 6.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio
- 6.7.5 MGC Diagnostics Recent Developments
- 6.8 Minato
- 6.8.1 Minato Company Information
- 6.8.2 Minato Business Overview
- 6.8.3 Minato Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Minato Pulmonary Function Testing Systems Product Portfolio
- 6.8.5 Minato Recent Developments
- 6.9 Ganshorn
- 6.9.1 Ganshorn Company Information
- 6.9.2 Ganshorn Business Overview
- 6.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Ganshorn Pulmonary Function Testing Systems Product Portfolio
- 6.9.5 Ganshorn Recent Developments
- 6.10 AESRI
- 6.10.1 AESRI Company Information
- 6.10.2 AESRI Business Overview
- 6.10.3 AESRI Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 AESRI Pulmonary Function Testing Systems Product Portfolio
- 6.10.5 AESRI Recent Developments
- 6.11 Morgan Scientific
- 6.11.1 Morgan Scientific Company Information
- 6.11.2 Morgan Scientific Business Overview
- 6.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Morgan Scientific Pulmonary Function Testing Systems Product Portfolio
- 6.11.5 Morgan Scientific Recent Developments
- 6.12 M&B
- 6.12.1 M&B Company Information
- 6.12.2 M&B Business Overview
- 6.12.3 M&B Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 M&B Pulmonary Function Testing Systems Product Portfolio
- 6.12.5 M&B Recent Developments
- 6.13 Sikeda
- 6.13.1 Sikeda Company Information
- 6.13.2 Sikeda Business Overview
- 6.13.3 Sikeda Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Sikeda Pulmonary Function Testing Systems Product Portfolio
- 6.13.5 Sikeda Recent Developments
- 6.14 RSDQ
- 6.14.1 RSDQ Company Information
- 6.14.2 RSDQ Business Overview
- 6.14.3 RSDQ Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 RSDQ Pulmonary Function Testing Systems Product Portfolio
- 6.14.5 RSDQ Recent Developments
7 North America by Country
- 7.1 North America Pulmonary Function Testing Systems Sales by Country
- 7.1.1 North America Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pulmonary Function Testing Systems Sales by Country (2021-2026)
- 7.1.3 North America Pulmonary Function Testing Systems Sales Forecast by Country (2027-2032)
- 7.2 North America Pulmonary Function Testing Systems Market Size by Country
- 7.2.1 North America Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pulmonary Function Testing Systems Market Size by Country (2021-2026)
- 7.2.3 North America Pulmonary Function Testing Systems Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pulmonary Function Testing Systems Sales by Country
- 8.1.1 Europe Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pulmonary Function Testing Systems Sales by Country (2021-2026)
- 8.1.3 Europe Pulmonary Function Testing Systems Sales Forecast by Country (2027-2032)
- 8.2 Europe Pulmonary Function Testing Systems Market Size by Country
- 8.2.1 Europe Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pulmonary Function Testing Systems Market Size by Country (2021-2026)
- 8.2.3 Europe Pulmonary Function Testing Systems Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pulmonary Function Testing Systems Sales by Country
- 9.1.1 Asia-Pacific Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pulmonary Function Testing Systems Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pulmonary Function Testing Systems Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pulmonary Function Testing Systems Market Size by Country
- 9.2.1 Asia-Pacific Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pulmonary Function Testing Systems Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pulmonary Function Testing Systems Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pulmonary Function Testing Systems Sales by Country
- 10.1.1 South America Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pulmonary Function Testing Systems Sales by Country (2021-2026)
- 10.1.3 South America Pulmonary Function Testing Systems Sales Forecast by Country (2027-2032)
- 10.2 South America Pulmonary Function Testing Systems Market Size by Country
- 10.2.1 South America Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pulmonary Function Testing Systems Market Size by Country (2021-2026)
- 10.2.3 South America Pulmonary Function Testing Systems Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pulmonary Function Testing Systems Sales by Country
- 11.1.1 Middle East and Africa Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pulmonary Function Testing Systems Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pulmonary Function Testing Systems Market Size by Country
- 11.2.1 Middle East and Africa Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pulmonary Function Testing Systems Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pulmonary Function Testing Systems Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pulmonary Function Testing Systems Value Chain Analysis
- 12.1.1 Pulmonary Function Testing Systems Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pulmonary Function Testing Systems Production Mode & Process
- 12.2 Pulmonary Function Testing Systems Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pulmonary Function Testing Systems Distributors
- 12.2.3 Pulmonary Function Testing Systems Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst